Varlam Kutateladze
Research Subjects
Research Interests
Varlam Kutateladze has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Ekaterina Seregina
Department of Economics Colby College
2 shared publications
Latest Publications
- 13 June 2024
- Published by Elsevier in Econometrics and Statistics
Doubly Sparse estimator for high-dimensional covariance matrices
- 13 June 2024
- Published by Elsevier in Econometrics and Statistics
Doubly Sparse estimator for high-dimensional covariance matrices
- 26 March 2021
- Published by School of Statistics, Renmin University of China in Journal of Data Science
- p. 390-408
Fast and Efficient Data Science Techniques for COVID-19 Group Testing
Researchers and public officials tend to agree that until a vaccine is readily available, stopping SARS-CoV-2 transmission is the name of the game. Testing is the key to preventing the spread, especially by asymptomatic individuals. With testing capacity restricted, group testing is an appealing alternative for comprehensive screening and has recently received FDA emergency authorization. This technique tests pools of individual samples, thereby often requiring fewer testing resources while potentially providing multiple folds of speedup. We approach group testing from a data science perspective and offer two contributions. First, we provide an extensive empirical comparison of modern group testing techniques based on simulated data. Second, we propose a simple one-round method based on ${\ell _{1}}$-norm sparse recovery, which outperforms current state-of-the-art approaches at certain disease prevalence rates.
- 26 March 2021
- Published by School of Statistics, Renmin University of China in Journal of Data Science
- p. 390-408
Fast and Efficient Data Science Techniques for COVID-19 Group Testing
Researchers and public officials tend to agree that until a vaccine is readily available, stopping SARS-CoV-2 transmission is the name of the game. Testing is the key to preventing the spread, especially by asymptomatic individuals. With testing capacity restricted, group testing is an appealing alternative for comprehensive screening and has recently received FDA emergency authorization. This technique tests pools of individual samples, thereby often requiring fewer testing resources while potentially providing multiple folds of speedup. We approach group testing from a data science perspective and offer two contributions. First, we provide an extensive empirical comparison of modern group testing techniques based on simulated data. Second, we propose a simple one-round method based on ${\ell _{1}}$-norm sparse recovery, which outperforms current state-of-the-art approaches at certain disease prevalence rates.